All Articles

Precise temperature control—fresh cells at ~4°C, cryopreserved below −130°C—determines stem cell viability during transport.

Multi-center stem cell trials report regional heart repair and strong safety but mixed long-term efficacy, high costs, and data integrity concerns.

Umbilical cord blood stem cells may reduce amyloid, lower inflammation and support brain repair in Alzheimer’s; early trials show safety and cord blood banking options.

How cord blood, cord tissue and placental banking preserves newborn stem cells for family use, treating 80+ conditions and enabling emerging therapies.

How AI boosts stem cell therapy success for autoimmune diseases by improving predictions, personalization, safety, and continuous monitoring.

Children fare far better than adults after stem cell transplants, but CAR T therapies, haploidentical grafts and cord blood banking are narrowing the gap.

Compare FACT and AABB accreditation for stem cell banking: scope, regulatory status, quality requirements, and what families should check for lab safety.

Compare slow-cooling, vitrification, and controlled-rate freezing for cord blood—trade-offs in CD34+ recovery, viability, oxidative stress, and storage risk.

Explains how stem cell therapy can regenerate heart tissue after a heart attack, improve LVEF, reduce heart failure risk, and current delivery challenges.